TorsinA and dystonia: from nuclear envelope to synapse

被引:46
作者
Granata, Alessandra [1 ]
Schiavo, Giampietro [2 ]
Warner, Thomas T. [1 ]
机构
[1] UCL Inst Neurol, Dept Clin Neurosci, London NW3 2PF, England
[2] Canc Res UK London Res Inst, Lincolns Inn Fields Labs, London, England
基金
英国惠康基金;
关键词
AAA plus chaperone; dopaminergic pathway; dystonia; DYT1; torsinA; EARLY-ONSET DYSTONIA; CAENORHABDITIS-ELEGANS EMBRYOS; TRANSGENIC MOUSE MODEL; TOR1A DYT1 GENE; DELTA-E-TORSINA; MUTANT TORSINA; PROTEIN TORSINA; HUMAN BRAIN; MOLECULAR CHAPERONES; ENDOPLASMIC-RETICULUM;
D O I
10.1111/j.1471-4159.2009.06095.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A GAG deletion in the DYT1 gene is responsible for the autosomal dominant movement disorder, early onset primary torsion dystonia, which is characterised by involuntary sustained muscle contractions and abnormal posturing of the limbs. The mutation leads to deletion of a single glutamate residue in the C-terminus of the protein torsinA, a member of the AAA+ ATPase family of proteins with multiple functions. Since no evidence of neurodegeneration has been found in DYT1 patients, the dystonic phenotype is likely to be the result of neuronal functional defect(s), the nature of which is only partially understood. Biochemical, structural and cell biological studies have been performed in order to characterise torsinA. These studies, together with the generation of several animal models, have contributed to identify cellular compartments and pathways, including the cytoskeleton and the nuclear envelope, the secretory pathway and the synaptic vesicle machinery where torsinA function may be crucial. However, the role of torsinA and the correlation between the dysfunction caused by the mutation and the dystonic phenotype remain unclear. This review provides an overview of the findings of the last ten years of research on torsinA, a critical evaluation of the different models proposed and insights towards future avenues of research.
引用
收藏
页码:1596 / 1609
页数:14
相关论文
共 119 条
  • [1] The dynein heavy chain: structure, mechanics and evolution
    Asai, DJ
    Koonce, MF
    [J]. TRENDS IN CELL BIOLOGY, 2001, 11 (05) : 196 - 202
  • [2] Decreased striatal D2 receptor binding in non-manifesting carriers of the DYT1 dystonia mutation
    Asanuma, K
    Ma, Y
    Okulski, J
    Dhawan, V
    Chaly, T
    Carbon, M
    Bressman, SB
    Eidelberg, D
    [J]. NEUROLOGY, 2005, 64 (02) : 347 - 349
  • [3] Augood Sarah J, 2004, Adv Neurol, V94, P53
  • [4] Augood SJ, 1999, ANN NEUROL, V46, P761, DOI 10.1002/1531-8249(199911)46:5<761::AID-ANA12>3.0.CO
  • [5] 2-Z
  • [6] Distribution and ultrastructural localization of torsinA immunoreactivity in the human brain
    Augood, SJ
    Keller-McGandy, CE
    Siriani, A
    Hewett, J
    Ramesh, V
    Sapp, E
    DiFiglia, M
    Breakefield, XO
    Standaert, DG
    [J]. BRAIN RESEARCH, 2003, 986 (1-2) : 12 - 21
  • [7] Dopamine transmission in DYT1 dystonia:: A biochemical and autoradiographical study
    Augood, SJ
    Hollingsworth, Z
    Albers, DS
    Yang, L
    Leung, JC
    Muller, B
    Klein, C
    Breakefield, XO
    Standaert, DG
    [J]. NEUROLOGY, 2002, 59 (03) : 445 - 448
  • [8] Expression of the early-onset torsion dystonia gene (DYT1) in human brain
    Augood, SJ
    Penney, JB
    Friberg, IK
    Breakefield, XO
    Young, AB
    Ozelius, LJ
    Standaert, DG
    [J]. ANNALS OF NEUROLOGY, 1998, 43 (05) : 669 - 673
  • [9] Dopamine release is impaired in a mouse model of DYT1 dystonia
    Balcioglu, Aygul
    Kim, Mee-Ohk
    Sharma, Nutan
    Cha, Jang-Ho
    Breakefield, Xandra O.
    Standaert, David G.
    [J]. JOURNAL OF NEUROCHEMISTRY, 2007, 102 (03) : 783 - 788
  • [10] Basham SE, 2001, DEVELOPMENT, V128, P4645